Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Your RPS

Reduced hospital admissions for care home residents in London

High-risk patients from 70 care homes in London received personalised care plans from a multi-disciplinary project team.

A two-year project which helped care homes improve medicines management and was a finalist the Pharmaceutical Care Awards 2015. In the image, pharmacist Hiral Khoda Vyas (left) and Nina Barnett (centre) discuss their project with PJ Editor Matthew Wright

Source: Simon Wright / The Pharmaceutical Journal

Pharmacists Hiral Khoda Vyas (left) and Nina Barnett (centre) discuss their finalist project, which helped care homes improve medicines use

A two-year project based in Harrow, North London, which helped care home residents and staff to improve medicines use, has saved up to £75,794 by reducing preventable hospital admissions and emergency callouts. The project team, led by elderly care GP Chris Jenner, secured a spot in the final of the Pharmaceutical Care Awards 2015. The event, jointly organised by the Royal Pharmaceutical Society and The Pharmaceutical Journal and supported by GlaxoSmithKline, was held at the Royal Society in London on 18 June 2015.

Consultant pharmacist Nina Barnett, who represented the team alongside specialist pharmacist Hiral Khoda Vyas at the awards, explained that the project was initiated because of the high number of local care home residents who were being admitted to hospital. “Part of the reason for this was that care home staff did not feel equipped to manage… the deterioration of health in care homes,” she added.

The multidisciplinary team, which consisted of a consultant geriatrician, a community nurse, a pharmacist and a mental health nurse specialist, worked across 70 care homes, helping to identify particular homes and patients who were at high risk. Patients were identified using a specially developed risk stratification tool. Medicines reviews were performed for these patients and a care plan was developed for each individual.

“Over six months, we did 229 reviews and we produced about 80 care plans,” Barnett explained. “What we were aiming to do was encourage the GPs to create these anticipatory care plans by giving them the information they needed from the patients, carers, relatives and staff.” She added that these care plans would then be embedded into practice at the care home so that staff did not have to call emergency services if the patient had further problems. “We weren’t going in, fixing everything and then leaving,” she said.

The project was commissioned by Harrow Clinical Commissioning Group with a budget of £208,242, and made an estimated annual net saving of £75,794.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068793

Readers' comments (1)

  • Is it possible to find out what risk stratification tool was used in this project?
    Many thanks,
    Ailsa Macdonald

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.